Truist Financial Corp Purchases 1,528 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Truist Financial Corp lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 82,770 shares of the company’s stock after buying an additional 1,528 shares during the period. Truist Financial Corp’s holdings in GE HealthCare Technologies were worth $6,471,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in GEHC. Blue Trust Inc. boosted its stake in GE HealthCare Technologies by 9.9% in the 3rd quarter. Blue Trust Inc. now owns 2,334 shares of the company’s stock worth $219,000 after purchasing an additional 210 shares during the period. Allspring Global Investments Holdings LLC boosted its stake in GE HealthCare Technologies by 2.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 24,693 shares of the company’s stock worth $2,317,000 after purchasing an additional 562 shares during the period. Sequoia Financial Advisors LLC boosted its stake in GE HealthCare Technologies by 42.5% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 13,217 shares of the company’s stock worth $1,240,000 after purchasing an additional 3,941 shares during the period. Signaturefd LLC boosted its stake in GE HealthCare Technologies by 4.0% in the 3rd quarter. Signaturefd LLC now owns 4,524 shares of the company’s stock worth $425,000 after purchasing an additional 174 shares during the period. Finally, Greenleaf Trust boosted its stake in GE HealthCare Technologies by 1.7% in the 3rd quarter. Greenleaf Trust now owns 7,619 shares of the company’s stock worth $715,000 after purchasing an additional 124 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Citigroup upped their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. Wells Fargo & Company upped their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $97.67.

GE HealthCare Technologies Trading Down 1.1 %

Shares of NASDAQ:GEHC opened at $91.09 on Friday. GE HealthCare Technologies Inc. has a 52-week low of $74.51 and a 52-week high of $94.80. The company has a market capitalization of $41.66 billion, a P/E ratio of 21.04, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. The company has a 50-day simple moving average of $85.05 and a 200 day simple moving average of $85.86. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.